Automated Imaging Diagnostics LLC

Automated Imaging Diagnostics LLC is a limited liability company registered in SAM.gov as a self-certified small disadvantaged business and for-profit organization. The company focuses on developing advanced medical imaging diagnostic software, specifically targeting neurodegenerative disease diagnosis. Their core technological innovation is a software platform called NeuroPACS, which utilizes artificial intelligence and magnetic resonance imaging (MRI) techniques to provide high-precision clinical diagnostic support, particularly in the field of Parkinsonism detection and classification.

The company has secured multiple federal grants from civilian agencies, including the National Institute of Neurological Disorders and Stroke, the National Institute on Aging, and the Center for Drug Evaluation and Research. These grants, totaling approximately $2-3 million, support the development of their NeuroPACS software, which aims to improve diagnostic accuracy for complex neurodegenerative conditions like Parkinson's Disease, Multiple System Atrophy Parkinsonian Variant, and Progressive Supranuclear Palsy. Their research focuses on developing advanced deep learning and artificial intelligence classification methods to analyze diffusion magnetic resonance imaging data, with the goal of creating a clinical decision support tool that can distinguish between different forms of Parkinsonism with over 90% accuracy. The research is particularly significant given the projected increase in Parkinsonism diagnoses, which are expected to reach 12-14 million patients by 2040, and the current high rates of misdiagnosis in the first five years after initial diagnosis.